In summary, results of this study indicate that patients with schizophrenia-spectrum disorders show altered levels of NR3C1 methylation that are significantly lower at early stages after the onset of psychosis and significantly higher after subsequent illness exacerbations. This evidence concerns the gene NR3C1 and psychotic disorder.